NCT05470387Phase 3Terminated

A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2023-03-06Actual

Enrollment · participants23Actual

Source updated2024-06-13Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Study details

Conditions studied

Ileus; Gastro-Intestinal Disorder

Treatments or interventions studied

LB1148DrugAlso known as Active
PlaceboDrug

Primary outcomes · main study measures

Read the study measures

measure: Time to Return of Gastrointestinal Function; description: The later of the times in hours from placement of the last skin staple or suture to the time of toleration of solid food (defined as the time a subject finished a meal that required chewing and experienced no significant nausea/vomiting for 4 hours after the solid meal) and the first bowel movement, up to 14 days post-surgery; timeFrame: From surgical procedure up to 14 days in hospital

History coverage

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

How to read this history